Abuse-Deterrent Hydrocodone Passes Phase 3Abuse-Deterrent Hydrocodone Passes Phase 3

Topline study results show that a new extended-release, single-entity, abuse-deterrent hydrocodone formulation significantly reduces back pain compared with placebo. Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news